The efficacy and safety of conventional transcatheter arterial chemoembolization combined with pd-1 inhibitor and anti-angiogenesis tyrosine kinase inhibitor treatment for patients with unresectable hepatocellular carcinoma: a real-world comparative study

HIGHLIGHTS

• who: Zheng Guo et al. from the Osaka University, Japan have published the research work: The efficacy and safety of conventional transcatheter arterial chemoembolization combined with PD-1 inhibitor and anti-angiogenesis tyrosine kinase inhibitor treatment for patients with unresectable hepatocellular carcinoma: a real-world comparative study, in the Journal: (JOURNAL) of March/31,/2022
• what: The study investigates the efficacy and safety of cTACE sequentially with PD-1 inhibitors and TKI treatment for unresectable HCC patients in the real world, which might be helpful for clinical decision-making in practice. The interval of sequential . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.